Vimarsana
Biggest News Aggregation in the World

Least Squares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Least Squares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Least Squares Today - Breaking & Trending Today

Uruguay: PGS receives approval to reprocess and expand Uruguay MC3D dataset - Vimarsana News

Uruguay: PGS receives approval to reprocess and expand Uruguay MC3D dataset

Originally acquired in 2012 (survey 3DUR12) and covering an area of 15 600 sq km, this data provides indispensable insights into Pelotas Basin prospectivity. The reprocessing sequence is designed to unlock further opportunities within these basins, helping to redefine exploration frontiers in this region.

PGS : Receives Approval to Reprocess and Expand Uruguay MC3D Dataset - Vimarsana News

PGS : Receives Approval to Reprocess and Expand Uruguay MC3D Dataset

PGS has received approval from ANCAP to reprocess and rejuvenate its Uruguay MC3D GeoStreamer dataset. Originally acquired in 2012 and covering an area of 15 600...

Kiniksa Pharmaceuticals Provides Corporate Update - Vimarsana News

Kiniksa Pharmaceuticals Provides Corporate Update

– ARCALYST® 2023 net product revenue grew ~90% year-over-year to $233.1 million – – ARCALYST 2024 net product revenue expected to be $360 - $380 million – – Abiprubart Phase 2...

Using Spectroscopy to Measure Quality Parameters for Jet Fuel - Vimarsana News

Using Spectroscopy to Measure Quality Parameters for Jet Fuel

This article from Process Insights outlines how spectroscopy can be used to measure quality parameters for jet fuel, creating an alternative approach that is more environmentally friendly and faster.

Source: azom.com
Shionogi says COVID pill resolves Omicron symptoms faster, meets trial's goal - Vimarsana News

Shionogi says COVID pill resolves Omicron symptoms faster, meets trial's goal

Shionogi (SGIOF) (SGIOY) said its oral COVID-19 drug S-217622 helped patients achieve resolution of five Omicron-related symptoms faster, compared to placebo, thereby meeting the main...